skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Cannabidiol (CBD) is being looked at more and more by health, beauty and wellness companies for its use in new OTC drugs, cosmetics and food supplements. It is highly controversial because while CBD has many natural health benefits for treating a variety of conditions and symptoms, it is the active ingredient extracted from cannabis which comes from hemp plants, and therefore has a number of regulatory and legal challenges for its use, but also offers some new market opportunities.

HBW Insight has been closely monitoring and reporting on the developments of CBD across the global consumer healthcare industry, which can be accessed from the timeline of articles below:



  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Japan's New Rx-To-OTC Procedure Exacerbating Switch Blockage Says JSMI

    By David Ridley

    Japan's new Rx-to-OTC switch procedure has exacerbated a "switch lag" compared with developed countries, says Japan Self-Medication Industry senior adviser Toshi Tominaga in an exclusive interview with HBW Insight. Tominaga proposes improvements such as self-care education for consumers and drug usage advice included by firms in switch applications to help balance the risk-benefit decisions of expert judges.

    Topics Policy and regulation

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Long-term E-cigarette Use Could Spark More Smoking, French Study Suggests

    By Malcolm Spicer

    Research in JAMA Internal Medicine studied "longitudinal associations between [e-cigarette] use and tobacco smoking patterns in a large population-based cohort study" and found use was associated with reduction in smoking and an increased probability of smoking cessation. But the researchers saw that e-cigarette users who quit tobacco "tended to relapse to smoking more frequently than" former smokers who didn't use e-cigarettes.

    Topics Medtech

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Informa Announces Date for OTC Marketing Awards 2020

    26 Jul 2019

    Informa Pharma Intelligence is pleased to announce that the 25th Annual OTC Marketing Awards will be held on Thursday, March 5, 2020. The ceremony for this year’s awards, which recognise the best of the British OTC industry, will return to the Royal Lancaster, London, UK.

    Topics Drug development landscape






電話:+81 (0)3 6273 4260